Impact of Work Activity on SUD Outcomes
Augmenting Early Phase Substance Use Treatment With Therapeutic Work Activity to Improve Clinical Outcomes: a New Indication for an Old Intervention
1 other identifier
interventional
103
1 country
1
Brief Summary
To date, there are no studies of the therapeutic effects of varied work-focused programs in Veterans undergoing outpatient substance use disorder (SUD) treatment. The investigators propose a randomized clinical trial to test the effects of work-focused programs on improving sobriety and other clinical outcomes in Veterans early in the course of recovery from SUD. Veterans will be randomized to either receive or not receive referral for work-focused therapeutic programs. Primary aim is to examine effects of work-focused programs on sobriety outcomes, namely sobriety and global functioning. Secondary aim is to examine effects of work-focused programs on psychiatric symptoms, self esteem/efficacy, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 20, 2021
CompletedStudy Start
First participant enrolled
January 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
September 17, 2025
September 1, 2025
6 years
July 1, 2021
September 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
percent days abstinent
percent days abstinent during 3-month active phase
3 months
Clinical Global Impression
Clinical Global Impression ratings conducted at 6 months from study entry.
6 months
Secondary Outcomes (4)
change from baseline in BASIS-24
3 months
change from baseline in Rosenberg self-esteem scale
6 months
change from baseline in New General Self-Efficacy Scale
6 months
change in WHOQOL BREF
6 months
Study Arms (2)
treatment as usual
ACTIVE COMPARATORusual substance use treatment
treatment as usual plus referral to work focused program
EXPERIMENTALusual substance use treatment plus referral to a competitive or non-competitive work-focused program
Interventions
referral to Incentive Therapy or to Other Therapeutic and Supported Employment Services
usual treatment
Eligibility Criteria
You may qualify if:
- Participants will be Veterans enrolled in VACHS substance use treatment, who at time of consenting into the study are within 30 days of detoxification or last substance use as per medical record.
- Additional criteria will be as follows:
- years of age and older,
- meeting DSM-V criteria for any current Substance Use Disorder (SUD) (e.g., opioids, cocaine, marijuana, amphetamine, or alcohol),
- competent to give written informed consent and HIPAA authorization.
You may not qualify if:
- involvement in a legal case that may lead to incarceration during study period;
- developmental disability or medical illness that would prevent therapeutic work activity, as judged by PI or clinical staff providing this service;
- plans to relocate outside geographic area that would make follow-up unlikely;
- and/or lack of willingness to provide contact information of someone who can help us contact the participant in the event that we are unable to maintain contact directly.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, 06516-2770, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna M. Fiszdon, PhD
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Assessors will be blind to randomization status.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2021
First Posted
July 20, 2021
Study Start
January 3, 2022
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
September 17, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- After study completion
- Access Criteria
- After study completion for no less than 7 years.
De-identified, anonymized dataset will be created. This dataset may be shared with other investigators, upon written request, under a data use agreement prohibiting the recipient from identifying or re-de-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. The data sharing agreement will also restrict redistribution to third parties and proper acknowledgment of the data source. These datasets will be shared per guidelines provided by VACHS Information Security Officer.